Eloquent AI | $7,400,000 | (Sep 12, 2025)
Meela Inc. | $3,500,000 | (Sep 12, 2025)
TrustNXT | $1,874,888 | (Sep 12, 2025)
Certified by Founder
Lodge
PetDx
start up
United States
- San Diego
- 09/12/2021
- Series B
- $62,000,000
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatic algorithms empowering veterinarians to provide superior care to canine patients.
- Industry Biotechnology Research
- Website https://petdx.com/
- LinkedIn https://www.linkedin.com/company/petdx/
Related People
Daniel S. GrosuFounder
United States -
San Diego, California,
Making the world a better place for pets... and their humans.
Kriya Therapeutics, Inc. | $320,000,000 | (Sep 12, 2025)
Goodpath | $18,000,000 | (Sep 12, 2025)
BacAlt | $2,037,362 | (Sep 12, 2025)
Quack AI | $7,000,000 | (Sep 12, 2025)
Diana Health (We're Hiring!) | $55,000,000 | (Sep 12, 2025)
OpenHealth Technologies | $3,000,000 | (Sep 12, 2025)
Brain Co. | $30,000,000 | (Sep 12, 2025)
AegisAI Security | $13,000,000 | (Sep 12, 2025)
Clyx | $14,000,000 | (Sep 12, 2025)